{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:22:06Z","timestamp":1790875326753,"version":"4.1.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T00:00:00Z","timestamp":1705276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T00:00:00Z","timestamp":1705276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hyperinflammation, hypercoagulation and endothelial injury are major findings in acute and post-COVID-19. The SARS-CoV-2\u2009S protein has been detected as an isolated element in human tissues reservoirs and is the main product of mRNA COVID-19 vaccines. We investigated whether the S protein alone triggers pro-inflammatory and pro-coagulant responses in primary cultures of two cell types deeply affected by SARS-CoV-2, such are monocytes and endothelial cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In human umbilical vein endothelial cells (HUVEC) and monocytes, the components of NF-\u03baB and the NLRP3 inflammasome system, as well as coagulation regulators, were assessed by qRT-PCR, Western blot, flow cytometry, or indirect immunofluorescence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>S protein activated NF-\u03baB, promoted pro-inflammatory cytokines release, and triggered the priming and activation of the NLRP3 inflammasome system resulting in mature IL-1\u03b2 formation in both cell types. This was paralleled by enhanced production of coagulation factors such as von Willebrand factor (vWF), factor VIII or tissue factor, that was mediated, at least in part, by IL-1\u03b2. Additionally, S protein failed to enhance ADAMTS-13 levels to counteract the pro-coagulant activity of vWF multimers. Monocytes and HUVEC barely expressed angiotensin-converting enzyme-2. Pharmacological approaches and gene silencing showed that TLR4 receptors mediated the effects of S protein in monocytes, but not in HUVEC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>S protein behaves both as a pro-inflammatory and pro-coagulant stimulus in human monocytes and endothelial cells. Interfering with the receptors or signaling pathways evoked by the S protein may help preventing immune and vascular complications driven by such an isolated viral element.<\/jats:p>\n                \n              <\/jats:sec>","DOI":"10.1186\/s12964-023-01397-6","type":"journal-article","created":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T09:02:27Z","timestamp":1705309347000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["SARS-CoV-2\u2009S protein activates NLRP3 inflammasome and deregulates coagulation factors in endothelial and immune cells"],"prefix":"10.1186","volume":"22","author":[{"given":"Alicia","family":"Villacampa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Alfaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"D\u00edaz-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"L\u00f3pez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Bartha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"L\u00f3pez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3scar","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Moncada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos F.","family":"S\u00e1nchez-Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Garc\u00eda-R\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Cubillos-Zapata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepci\u00f3n","family":"Peir\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,15]]},"reference":[{"key":"1397_CR1","unstructured":"World Health Organization. COVID-19 epidemiological update (Edition 160).  2023. [cited 2023 October 28]. Available from:  https:\/\/www.who.int\/publications\/m\/item\/covid-19-epidemiological-update---27-october-2023."},{"key":"1397_CR2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12985-023-02061-8","volume":"20","author":"C Wang","year":"2023","unstructured":"Wang C, Ramasamy A, Verduzco-Gutierrez M, Brode WM, Melamed E. Acute and post-acute sequelae of SARS-CoV-2 infection: a review of risk factors and social determinants. Virol J. 2023;20:124.","journal-title":"Virol J."},{"key":"1397_CR3","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","volume":"41","author":"Y Huang","year":"2020","unstructured":"Huang Y, Yang C, Xu XF, Xu W, Liu SW. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol Sin. 2020;41:1141\u20139.","journal-title":"Acta Pharmacol Sin."},{"key":"1397_CR4","doi-asserted-by":"crossref","unstructured":"Watanabe Y, Allen JD, Wrapp D, McLellan JS, Crispin M. Site-specific glycan analysis of the SARS-CoV-2 spike. Science. 2020;369:330\u20133.","DOI":"10.1126\/science.abb9983"},{"key":"1397_CR5","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","volume":"426","author":"W Li","year":"2003","unstructured":"Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450\u20134.","journal-title":"Nature."},{"key":"1397_CR6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"J Lan","year":"2020","unstructured":"Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S, Zhang Q, Shi X, Wang Q, Zhang L, Wang X. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581:215\u201320.","journal-title":"Nature."},{"key":"1397_CR7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-020-00426-x","volume":"5","author":"K Wang","year":"2020","unstructured":"Wang K, Chen W, Zhang Z, Deng Y, Lian JQ, Du P, Wei D, Zhang Y, Sun XX, Gong L, et al. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct Target Ther. 2020;5:283.","journal-title":"Signal Transduct Target Ther."},{"key":"1397_CR8","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3389\/fphar.2020.01161","volume":"11","author":"I Valencia","year":"2020","unstructured":"Valencia I, Peiro C, Lorenzo O, Sanchez-Ferrer CF, Eckel J, Romacho T. DPP4 and ACE2 in diabetes and COVID-19: therapeutic targets for cardiovascular complications? Front Pharmacol. 2020;11:1161.","journal-title":"Front Pharmacol."},{"key":"1397_CR9","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1042\/CS20210735","volume":"135","author":"E Avolio","year":"2021","unstructured":"Avolio E, Carrabba M, Milligan R, Kavanagh Williamson M, Beltrami AP, Gupta K, Elvers KT, Gamez M, Foster RR, Gillespie K, et al. The SARS-CoV-2 spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease. Clin Sci (Lond). 2021;135:2667\u201389.","journal-title":"Clin Sci (Lond)."},{"key":"1397_CR10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41569-020-00469-1","volume":"18","author":"SX Gu","year":"2021","unstructured":"Gu SX, Tyagi T, Jain K, Gu VW, Lee SH, Hwa JM, Kwan JM, Krause DS, Lee AI, Halene S, et al. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nat Rev Cardiol. 2021;18:194\u2013209.","journal-title":"Nat Rev Cardiol."},{"key":"1397_CR11","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417\u20138.","journal-title":"Lancet."},{"key":"1397_CR12","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/his.14134","volume":"77","author":"T Menter","year":"2020","unstructured":"Menter T, Haslbauer JD, Nienhold R, Savic S, Hopfer H, Deigendesch N, Frank S, Turek D, Willi N, Pargger H, et al. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathol. 2020;77:198\u2013209.","journal-title":"Histopathol."},{"key":"1397_CR13","doi-asserted-by":"crossref","first-page":"824851","DOI":"10.3389\/fcell.2022.824851","volume":"10","author":"B Martinez-Salazar","year":"2022","unstructured":"Martinez-Salazar B, Holwerda M, Studle C, Piragyte I, Mercader N, Engelhardt B, Rieben R, Doring Y. COVID-19 and the vasculature: current aspects and long-term consequences. Front Cell Dev Biol. 2022;10:824851.","journal-title":"Front Cell Dev Biol."},{"key":"1397_CR14","doi-asserted-by":"crossref","unstructured":"Zanini G, Selleri V, Roncati L, Coppi F, Nasi M, Farinetti A, Manenti A, Pinti M, Mattioli AV. Vascular \"long COVID\": a new vessel disease? Angiol. 2023;18:33197231153204.","DOI":"10.1177\/00033197231153204"},{"key":"1397_CR15","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.abb8925","volume":"368","author":"JB Moore","year":"2020","unstructured":"Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368:473\u20134.","journal-title":"Science."},{"key":"1397_CR16","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1182\/blood-2018-11-882993","volume":"133","author":"SP Jackson","year":"2019","unstructured":"Jackson SP, Darbousset R, Schoenwaelder SM. Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms. Blood. 2019;133:906\u201318.","journal-title":"Blood."},{"key":"1397_CR17","doi-asserted-by":"crossref","first-page":"847894","DOI":"10.3389\/fimmu.2022.847894","volume":"13","author":"E Diaz-Garcia","year":"2022","unstructured":"Diaz-Garcia E, Garcia-Tovar S, Alfaro E, Zamarron E, Mangas A, Galera R, Ruiz-Hernandez JJ, Sole-Violan J, Rodriguez-Gallego C, Van-Den-Rym A, et al. Role of CD39 in COVID-19 severity: dysregulation of purinergic signaling and Thromboinflammation. Front Immunol. 2022;13:847894.","journal-title":"Front Immunol."},{"key":"1397_CR18","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s13054-020-03077-0","volume":"24","author":"T Iba","year":"2020","unstructured":"Iba T, Levy JH, Connors JM, Warkentin TE, Thachil J, Levi M. The unique characteristics of COVID-19 coagulopathy. Crit Care. 2020;24:360.","journal-title":"Crit Care."},{"key":"1397_CR19","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/j.1538-7836.2005.01373.x","volume":"3","author":"J Polgar","year":"2005","unstructured":"Polgar J, Matuskova J, Wagner DD. The P-selectin, tissue factor, coagulation triad. J Thromb Haemost. 2005;3:1590\u20136.","journal-title":"J Thromb Haemost."},{"key":"1397_CR20","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41419-020-02985-x","volume":"11","author":"B Bai","year":"2020","unstructured":"Bai B, Yang Y, Wang Q, Li M, Tian C, Liu Y, Aung LHH, Li PF, Yu T, Chu XM. NLRP3 inflammasome in endothelial dysfunction. Cell Death Dis. 2020;11:776.","journal-title":"Cell Death Dis."},{"key":"1397_CR21","doi-asserted-by":"crossref","first-page":"108053","DOI":"10.1016\/j.pharmthera.2021.108053","volume":"236","author":"S Toldo","year":"2022","unstructured":"Toldo S, Mezzaroma E, Buckley LF, Potere N, Di Nisio M, Biondi-Zoccai G, Van Tassell BW, Abbate A. Targeting the NLRP3 inflammasome in cardiovascular diseases. Pharmacol Ther. 2022;236:108053.","journal-title":"Pharmacol Ther."},{"key":"1397_CR22","doi-asserted-by":"crossref","unstructured":"Ding S, Xu S, Ma Y, Liu G, Jang H, Fang J. Modulatory mechanisms of the NLRP3 Inflammasomes in diabetes. Biomolecules. 2019;9:850.","DOI":"10.3390\/biom9120850"},{"key":"1397_CR23","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1164\/rccm.202106-1445OC","volume":"205","author":"E Diaz-Garcia","year":"2022","unstructured":"Diaz-Garcia E, Garcia-Tovar S, Alfaro E, Jaureguizar A, Casitas R, Sanchez-Sanchez B, Zamarron E, Fernandez-Lahera J, Lopez-Collazo E, Cubillos-Zapata C, Garcia-Rio F. Inflammasome activation: a keystone of Proinflammatory response in obstructive sleep apnea. Am J Respir Crit Care Med. 2022;205:1337\u201348.","journal-title":"Am J Respir Crit Care Med."},{"key":"1397_CR24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fimmu.2020.00211","volume":"11","author":"C Zhao","year":"2020","unstructured":"Zhao C, Zhao W. NLRP3 Inflammasome-a key player in antiviral responses. Front Immunol. 2020;11:211.","journal-title":"Front Immunol."},{"key":"1397_CR25","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","volume":"41","author":"Y He","year":"2016","unstructured":"He Y, Hara H, Nunez G. Mechanism and regulation of NLRP3 Inflammasome activation. Trends Biochem Sci. 2016;41:1012\u201321.","journal-title":"Trends Biochem Sci."},{"key":"1397_CR26","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/cr.2015.139","volume":"25","author":"WT He","year":"2015","unstructured":"He WT, Wan H, Hu L, Chen P, Wang X, Huang Z, Yang ZH, Zhong CQ, Han J. Gasdermin D is an executor of pyroptosis and required for interleukin-1beta secretion. Cell Res. 2015;25:1285\u201398.","journal-title":"Cell Res."},{"key":"1397_CR27","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.cell.2014.04.007","volume":"157","author":"M Lamkanfi","year":"2014","unstructured":"Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes. Cell. 2014;157:1013\u201322.","journal-title":"Cell."},{"key":"1397_CR28","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC. NF-kappaB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023.","journal-title":"Signal Transduct Target Ther."},{"key":"1397_CR29","doi-asserted-by":"crossref","first-page":"827146","DOI":"10.3389\/fimmu.2022.827146","volume":"13","author":"L Perico","year":"2022","unstructured":"Perico L, Morigi M, Galbusera M, Pezzotta A, Gastoldi S, Imberti B, Perna A, Ruggenenti P, Donadelli R, Benigni A, Remuzzi G. SARS-CoV-2 spike protein 1 activates microvascular endothelial cells and complement system leading to platelet aggregation. Front Immunol. 2022;13:827146.","journal-title":"Front Immunol."},{"key":"1397_CR30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.14336\/AD.2021.0617","volume":"13","author":"A Romero","year":"2022","unstructured":"Romero A, Dongil P, Valencia I, Vallejo S, Hipolito-Luengo AS, Diaz-Araya G, Bartha JL, Gonzalez-Arlanzon MM, Rivilla F, de la Cuesta F, et al. Pharmacological blockade of NLRP3 Inflammasome\/IL-1beta-positive loop mitigates endothelial cell senescence and dysfunction. Aging Dis. 2022;13:284\u201397.","journal-title":"Aging Dis."},{"key":"1397_CR31","doi-asserted-by":"crossref","first-page":"e12913","DOI":"10.1111\/acel.12913","volume":"18","author":"A Romero","year":"2019","unstructured":"Romero A, San Hipolito-Luengo A, Villalobos LA, Vallejo S, Valencia I, Michalska P, Pajuelo-Lozano N, Sanchez-Perez I, Leon R, Bartha JL, et al. The angiotensin-(1-7)\/mas receptor axis protects from endothelial cell senescence via klotho and Nrf2 activation. Aging Cell. 2019;18:e12913.","journal-title":"Aging Cell."},{"key":"1397_CR32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-1-62703-523-1_8","volume":"1040","author":"A Stutz","year":"2013","unstructured":"Stutz A, Horvath GL, Monks BG, Latz E. ASC speck formation as a readout for inflammasome activation. Methods Mol Biol. 2013;1040:91\u2013101.","journal-title":"Methods Mol Biol."},{"key":"1397_CR33","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.1038\/s41598-020-62190-w","volume":"10","author":"T Romacho","year":"2020","unstructured":"Romacho T, Valencia I, Ramos-Gonzalez M, Vallejo S, Lopez-Esteban M, Lorenzo O, Cannata P, Romero A, San Hipolito-Luengo A, Gomez-Cerezo JF, et al. Visfatin\/eNampt induces endothelial dysfunction in vivo: a role for toll-like receptor 4 and NLRP3 inflammasome. Sci Rep. 2020;10:5386.","journal-title":"Sci Rep."},{"key":"1397_CR34","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1111\/jth.15873","volume":"20","author":"V DeYoung","year":"2022","unstructured":"DeYoung V, Singh K, Kretz CA. Mechanisms of ADAMTS13 regulation. J Thromb Haemost. 2022;20:2722\u201332.","journal-title":"J Thromb Haemost."},{"key":"1397_CR35","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/CIRCRESAHA.116.306853","volume":"118","author":"JH Foley","year":"2016","unstructured":"Foley JH, Conway EM. Cross talk pathways between coagulation and inflammation. Circ Res. 2016;118:1392\u2013408.","journal-title":"Circ Res."},{"key":"1397_CR36","first-page":"36","volume":"13","author":"H Vaez","year":"2023","unstructured":"Vaez H, Soraya H, Garjani A, Gholikhani T. Toll-like receptor 4 (TLR4) and AMPK relevance in cardiovascular disease. Adv Pharm Bull. 2023;13:36\u201347.","journal-title":"Adv Pharm Bull."},{"key":"1397_CR37","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","volume":"20","author":"M Merad","year":"2020","unstructured":"Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20:355\u201362.","journal-title":"Nat Rev Immunol."},{"key":"1397_CR38","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.0901363","volume":"183","author":"FG Bauernfeind","year":"2009","unstructured":"Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, Fernandes-Alnemri T, Wu J, Monks BG, Fitzgerald KA, et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol. 2009;183:787\u201391.","journal-title":"J Immunol."},{"key":"1397_CR39","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.3389\/fimmu.2018.01789","volume":"9","author":"B Hosseinkhani","year":"2018","unstructured":"Hosseinkhani B, Kuypers S, Van den Akker NM, Molin DG, Michiels L. Extracellular vesicles work as a functional inflammatory mediator between vascular endothelial cells and immune cells. Front Immunol. 2018;9:1789.","journal-title":"Front Immunol."},{"key":"1397_CR40","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.3389\/fimmu.2020.01580","volume":"11","author":"DF van den Berg","year":"2020","unstructured":"van den Berg DF, Te Velde AA. Severe COVID-19: NLRP3 Inflammasome dysregulated. Front Immunol. 2020;11:1580.","journal-title":"Front Immunol."},{"key":"1397_CR41","doi-asserted-by":"crossref","first-page":"118114","DOI":"10.1016\/j.lfs.2020.118114","volume":"257","author":"A Paniri","year":"2020","unstructured":"Paniri A, Akhavan-Niaki H. Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: role of lncRNAs in cytokine storm modulation. Life Sci. 2020;257:118114.","journal-title":"Life Sci."},{"key":"1397_CR42","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, et al. Antiinflammatory therapy with Canakinumab for atherosclerotic disease. N Engl J Med. 2017;377:1119\u201331.","journal-title":"N Engl J Med."},{"key":"1397_CR43","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1016\/S2213-2600(20)30216-2","volume":"8","author":"RJ Jose","year":"2020","unstructured":"Jose RJ, Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir Med. 2020;8:e46\u20137.","journal-title":"Lancet Respir Med."},{"key":"1397_CR44","doi-asserted-by":"crossref","unstructured":"Kole C, Stefanou E, Karvelas N, Schizas D, Toutouzas KP. Acute and post-acute COVID-19 cardiovascular complications: a comprehensive review. Cardiovasc Drugs Ther. 2023:1\u201316.","DOI":"10.1007\/s10557-023-07465-w"},{"key":"1397_CR45","doi-asserted-by":"crossref","first-page":"e807","DOI":"10.1002\/iid3.807","volume":"11","author":"F Yasmin","year":"2023","unstructured":"Yasmin F, Najeeb H, Naeem U, Moeed A, Atif AR, Asghar MS, Nimri N, Saleem M, Bandyopadhyay D, Krittanawong C, et al. Adverse events following COVID-19 mRNA vaccines: a systematic review of cardiovascular complication, thrombosis, and thrombocytopenia. Immun Inflamm Dis. 2023;11:e807.","journal-title":"Immun Inflamm Dis."},{"key":"1397_CR46","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/CIRCULATIONAHA.122.061025","volume":"147","author":"LM Yonker","year":"2023","unstructured":"Yonker LM, Swank Z, Bartsch YC, Burns MD, Kane A, Boribong BP, Davis JP, Loiselle M, Novak T, Senussi Y, et al. Circulating spike protein detected in post-COVID-19 mRNA vaccine myocarditis. Circulation. 2023;147:867\u201376.","journal-title":"Circulation."},{"key":"1397_CR47","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/bjh.17273","volume":"192","author":"SE Ward","year":"2021","unstructured":"Ward SE, Curley GF, Lavin M, Fogarty H, Karampini E, McEvoy NL, Clarke J, Boylan M, Alalqam R, Worrall AP, et al. Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activation. Br J Haematol. 2021;192:714\u20139.","journal-title":"Br J Haematol."},{"key":"1397_CR48","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","volume":"7","author":"G Goshua","year":"2020","unstructured":"Goshua G, Pine AB, Meizlish ML, Chang CH, Zhang H, Bahel P, Baluha A, Bar N, Bona RD, Burns AJ, et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-Centre, cross-sectional study. Lancet Haematol. 2020;7:e575\u201382.","journal-title":"Lancet Haematol."},{"key":"1397_CR49","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijid.2021.06.051","volume":"117","author":"A Wibowo","year":"2022","unstructured":"Wibowo A, Pranata R, Lim MA, Akbara MR, Martha JW. Endotheliopathy marked by high von Willebrand factor (vWF) antigen in COVID-19 is associated with poor outcome: a systematic review and meta-analysis. Int J Infect Dis. 2022;117:267\u201373.","journal-title":"Int J Infect Dis."},{"key":"1397_CR50","doi-asserted-by":"crossref","first-page":"200333","DOI":"10.1098\/rsob.200333","volume":"10","author":"S Santamaria","year":"2020","unstructured":"Santamaria S, de Groot R. ADAMTS proteases in cardiovascular physiology and disease. Open Biol. 2020;10:200333.","journal-title":"Open Biol."},{"key":"1397_CR51","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1538-7836.2006.01833.x","volume":"4","author":"HB Feys","year":"2006","unstructured":"Feys HB, Liu F, Dong N, Pareyn I, Vauterin S, Vandeputte N, Noppe W, Ruan C, Deckmyn H, Vanhoorelbeke K. ADAMTS-13 plasma level determination uncovers antigen absence in acquired thrombotic thrombocytopenic purpura and ethnic differences. J Thromb Haemost. 2006;4:955\u201362.","journal-title":"J Thromb Haemost."},{"key":"1397_CR52","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11239-021-02457-9","volume":"52","author":"A Marco","year":"2021","unstructured":"Marco A, Marco P. Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19. J Thromb Thrombol. 2021;52:497\u2013503.","journal-title":"J Thromb Thrombol."},{"key":"1397_CR53","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/jth.15191","volume":"19","author":"I Mancini","year":"2021","unstructured":"Mancini I, Baronciani L, Artoni A, Colpani P, Biganzoli M, Cozzi G, Novembrino C, Boscolo Anzoletti M, De Zan V, Pagliari MT, et al. The ADAMTS13-von Willebrand factor axis in COVID-19 patients. J Thromb Haemost. 2021;19:513\u201321.","journal-title":"J Thromb Haemost."},{"key":"1397_CR54","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1111\/jth.15830","volume":"20","author":"H Fogarty","year":"2022","unstructured":"Fogarty H, Ward SE, Townsend L, Karampini E, Elliott S, Conlon N, Dunne J, Kiersey R, Naughton A, Gardiner M, et al. Sustained VWF-ADAMTS-13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction. J Thromb Haemost. 2022;20:2429\u201338.","journal-title":"J Thromb Haemost."},{"key":"1397_CR55","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11239-020-02172-x","volume":"50","author":"M Bautista-Vargas","year":"2020","unstructured":"Bautista-Vargas M, Bonilla-Abadia F, Canas CA. Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19. J Thromb Thrombol. 2020;50:479\u201383.","journal-title":"J Thromb Thrombol."},{"key":"1397_CR56","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2174\/1389450123666220926144432","volume":"23","author":"TAA Sachetto","year":"2022","unstructured":"Sachetto TAA, Mackman N. Tissue factor and COVID-19: an update. Curr Drug Targets. 2022;23:1573\u20137.","journal-title":"Curr Drug Targets."},{"key":"1397_CR57","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.thromres.2022.08.017","volume":"218","author":"X Xu","year":"2022","unstructured":"Xu X, Feng Y, Jia Y, Zhang X, Li L, Bai X, Jiao L. Prognostic value of von Willebrand factor and ADAMTS13 in patients with COVID-19: a systematic review and meta-analysis. Thromb Res. 2022;218:83\u201398.","journal-title":"Thromb Res."},{"key":"1397_CR58","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1111\/jth.14246","volume":"16","author":"H Zelaya","year":"2018","unstructured":"Zelaya H, Rothmeier AS, Ruf W. Tissue factor at the crossroad of coagulation and cell signaling. J Thromb Haemost. 2018;16:1941\u201352.","journal-title":"J Thromb Haemost."},{"key":"1397_CR59","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jaci.2022.05.029","volume":"150","author":"A Bertoni","year":"2022","unstructured":"Bertoni A, Penco F, Mollica H, Bocca P, Prigione I, Corcione A, Cangelosi D, Schena F, Del Zotto G, Amaro A. Spontaneous NLRP3 inflammasome-driven IL-1-\u03b2 secretion is induced in severe COVID-19 patients and responds to anakinra treatment. J Allergy Clin Immunol. 2022;150:796\u2013805.","journal-title":"J Allergy Clin Immunol."},{"key":"1397_CR60","doi-asserted-by":"crossref","first-page":"831763","DOI":"10.3389\/fimmu.2022.831763","volume":"13","author":"JT Schroeder","year":"2022","unstructured":"Schroeder JT, Bieneman AP. The S1 subunit of the SARS-CoV-2 spike protein activates human monocytes to produce cytokines linked to COVID-19: relevance to Galectin-3. Front Immunol. 2022;13:831763.","journal-title":"Front Immunol."},{"key":"1397_CR61","doi-asserted-by":"crossref","unstructured":"Guo Y, Kanamarlapudi V. Molecular analysis of SARS-CoV-2 spike protein-induced endothelial cell permeability and vWF secretion. Int J Mol Sci. 2023;24;5664.","DOI":"10.3390\/ijms24065664"},{"key":"1397_CR62","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","volume":"586","author":"F Krammer","year":"2020","unstructured":"Krammer F. SARS-CoV-2 vaccines in development. Nature. 2020;586:516\u201327.","journal-title":"Nature."},{"key":"1397_CR63","doi-asserted-by":"crossref","unstructured":"Bettini E, Locci M. SARS-CoV-2 mRNA vaccines: immunological mechanism and beyond. Vaccines (Basel). 2021;9:147.","DOI":"10.3390\/vaccines9020147"},{"key":"1397_CR64","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1111\/all.14429","volume":"75","author":"U Radzikowska","year":"2020","unstructured":"Radzikowska U, Ding M, Tan G, Zhakparov D, Peng Y, Wawrzyniak P, Wang M, Li S, Morita H, Altunbulakli C, et al. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy. 2020;75:2829\u201345.","journal-title":"Allergy."},{"key":"1397_CR65","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/JLB.4COVA1121-579RR","volume":"112","author":"U Zankharia","year":"2022","unstructured":"Zankharia U, Yadav A, Yi Y, Hahn BH, Collman RG. Highly restricted SARS-CoV-2 receptor expression and resistance to infection by primary human monocytes and monocyte-derived macrophages. J Leukoc Biol. 2022;112:569\u201376.","journal-title":"J Leukoc Biol."},{"key":"1397_CR66","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/CIRCULATIONAHA.120.052824","volume":"143","author":"IR McCracken","year":"2021","unstructured":"McCracken IR, Saginc G, He L, Huseynov A, Daniels A, Fletcher S, Peghaire C, Kalna V, Andaloussi-Mae M, Muhl L, et al. Lack of evidence of angiotensin-converting enzyme 2 expression and replicative infection by SARS-CoV-2 in human endothelial cells. Circulation. 2021;143:865\u20138.","journal-title":"Circulation."},{"key":"1397_CR67","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.stemcr.2022.03.016","volume":"17","author":"L Muhl","year":"2022","unstructured":"Muhl L, He L, Sun Y, Andaloussi Mae M, Pietila R, Liu J, Genove G, Zhang L, Xie Y, Leptidis S, et al. The SARS-CoV-2 receptor ACE2 is expressed in mouse pericytes but not endothelial cells: implications for COVID-19 vascular research. Stem Cell Rep. 2022;17:1089\u2013104.","journal-title":"Stem Cell Rep."},{"key":"1397_CR68","doi-asserted-by":"crossref","first-page":"101160","DOI":"10.1016\/j.isci.2020.101160","volume":"23","author":"Y Li","year":"2020","unstructured":"Li Y, Zhang Z, Yang L, Lian X, Xie Y, Li S, Xin S, Cao P, Lu J. The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike. iScience. 2020;23:101160.","journal-title":"iScience."},{"key":"1397_CR69","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.atherosclerosis.2009.09.075","volume":"209","author":"WK den Dekker","year":"2010","unstructured":"den Dekker WK, Cheng C, Pasterkamp G, Duckers HJ. Toll like receptor 4 in atherosclerosis and plaque destabilization. Atherosclerosis. 2010;209:314\u201320.","journal-title":"Atherosclerosis."},{"key":"1397_CR70","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1038\/jcbfm.2008.50","volume":"28","author":"QW Yang","year":"2008","unstructured":"Yang QW, Li JC, Lu FL, Wen AQ, Xiang J, Zhang LL, Huang ZY, Wang JZ. Upregulated expression of toll-like receptor 4 in monocytes correlates with severity of acute cerebral infarction. J Cereb Blood Flow Metab. 2008;28:1588\u201396.","journal-title":"J Cereb Blood Flow Metab."},{"key":"1397_CR71","doi-asserted-by":"crossref","first-page":"568396","DOI":"10.1155\/2010\/568396","volume":"2010","author":"X Wittebole","year":"2010","unstructured":"Wittebole X, Castanares-Zapatero D, Laterre PF. Toll-like receptor 4 modulation as a strategy to treat sepsis. Mediat Inflamm. 2010;2010:568396.","journal-title":"Mediat Inflamm."},{"key":"1397_CR72","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","volume":"42","author":"YC Lu","year":"2008","unstructured":"Lu YC, Yeh WC, Ohashi PS. LPS\/TLR4 signal transduction pathway. Cytokine. 2008;42:145\u201351.","journal-title":"Cytokine."},{"key":"1397_CR73","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/14728222.2021.1918103","volume":"25","author":"D Kaushik","year":"2021","unstructured":"Kaushik D, Bhandari R, Kuhad A. TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2. Expert Opin Ther Targets. 2021;25:491\u2013508.","journal-title":"Expert Opin Ther Targets."},{"key":"1397_CR74","doi-asserted-by":"crossref","first-page":"e487","DOI":"10.1093\/cid\/ciac722","volume":"76","author":"Z Swank","year":"2023","unstructured":"Swank Z, Senussi Y, Manickas-Hill Z, Yu XG, Li JZ, Alter G, Walt DR. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin Infect Dis. 2023;76:e487\u201390.","journal-title":"Clin Infect Dis."},{"key":"1397_CR75","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133\u201346.","journal-title":"Nat Rev Microbiol."},{"key":"1397_CR76","volume-title":"SARS-CoV-2 spike protein accumulation in the skull-MeningesBrain Axis: potential implications for long-term neurological complications in post-COVID-19","author":"Z Rong","year":"2023","unstructured":"Rong Z, Mai H, Kapoor S, Puelles VG, Czogalla J, Sch\u00e4dler J, Vering J, Delbridge C, Steinke H, Frenzel H, et al: SARS-CoV-2 spike protein accumulation in the skull-MeningesBrain Axis: potential implications for long-term neurological complications in post-COVID-19. 2023."}],"updated-by":[{"DOI":"10.1186\/s12964-024-01491-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000}}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-023-01397-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-023-01397-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-023-01397-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T14:34:07Z","timestamp":1706106847000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-023-01397-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,15]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1397"],"URL":"https:\/\/doi.org\/10.1186\/s12964-023-01397-6","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12964-024-01491-3","asserted-by":"object"}]},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,15]]},"assertion":[{"value":"23 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by local ethics committee at La Paz University Hospital (PI-3486 and PI-4087), and informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}